Back to Screener

Healthcare

Protalix BioTherapeutics, Inc.(PLX)

Live Price

Offline

$2.22

+9.90% today

1Y Change

+58.57%

Window

Jun 20, 2025 β†’ Jun 18, 2026

Market Cap
$170.00M
Revenue Growth
-1.2%
EPS Growth
-308.2%
Dividend Yield
0.0%

Coverage: 250 bars Β· Jun 20, 2025 β†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Protalix BioTherapeutics, Inc. (PLX) is a Healthcare stock with a market cap of $170.00M and listed on AMEX. The stock last traded around $2.22 and up 58.6% across the available one-year price window (Jun 20, 2025 β†’ Jun 18, 2026). Baseline metrics include revenue growth of -1.2%, EPS growth of -308.2%, a dividend yield of 0.0%. What stands out right now is revenue -1.2%, EPS -308.2%, free cash flow -284.4% with operating margin -10.4% and ROIC -9.6%. Valuation is more restrained than many high-expectation growth names at price/sales 3.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PLX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

PLX

β€”

Normalized return

SPY

β€”

S&P 500

Excess Return

β€”

Relative to SPY

PLX Max Drawdown

-39.68%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for PLX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

πŸ“… Last reportedMay 8, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”Report
β€”
May 8, 26
β€”
Est -0.01
β€”
β€”
Est 11500.0B
β€”
May 8
β€”
Mar 18, 26
βœ—
-0.07
Est 0.01
-800.0%
9124.0B
Est 18300.0B
-50.1%
Mar 18
β€”
Nov 13, 25
βœ—
0.03
Est 0.06
-50.0%
17851.0B
Est 14244.0B
+25.3%
Nov 13
β€”
Aug 14, 25
βœ—
0.00
Est 0.03
-93.3%
15658.0B
Est 13486.0B
+16.1%
Aug 14
β€”
May 9, 25
βœ—
-0.05
Est 0.08
-162.5%
10113.0B
Est 23100.0B
-56.2%
May 9
β€”
Mar 17, 25
βœ“
0.09
Est 0.07
+28.6%
18218.0B
Est 21600.0B
-15.7%
Mar 17
β€”
Nov 14, 24
βœ—
0.03
Est 0.06
-50.0%
17959.0B
Est 18206.0B
-1.4%
Nov 14
β€”
Aug 14, 24
βœ—
-0.03
Est -0.01
-250.1%
13474.0B
Est 3748.0B
+259.5%
Aug 14
β€”
May 10, 24
βœ—
-0.06
Est -0.02
-200.0%
3748.0B
Est 9200.0B
-59.3%
May 10
β€”
Mar 14, 24
βœ—
-0.07
Est -0.03
-133.3%
10486.0B
Est 5800.0B
+80.8%
Mar 14
β€”
Nov 6, 23
βœ“
-0.04
Est -0.07
+42.9%
10345.0B
Est 8120.0B
+27.4%
Nov 6
β€”
Aug 7, 23
βœ“
0.21
Est 0.03
+624.9%
35075.0B
Est 18250.0B
+92.2%
Aug 7
β€”
May 4, 23
-0.05
Est β€”
β€”
9588.0B
Est β€”
β€”
May 4
β€”
Feb 27, 23
βœ“
-0.07
Est -0.15
+53.3%
8617.0B
Est 6120.0B
+40.8%
Feb 27
β€”
Nov 14, 22
βœ“
-0.07
Est -0.15
+53.3%
14183.0B
Est 5695.0B
+149.0%
Nov 14
β€”
Aug 15, 22
βœ“
-0.11
Est -0.18
+38.9%
8753.0B
Est 2675.0B
+227.2%
Aug 15
β€”
May 16, 22
βœ—
-0.05
Est -0.04
-25.0%
16085.0B
Est 15500.0B
+3.8%
May 16
β€”
Mar 31, 22
βœ—
-0.14
Est -0.11
-27.3%
8549.0B
Est 7790.0B
+9.7%
Mar 31
β€”
Nov 15, 21
βœ“
-0.09
Est -0.12
+25.0%
12054.0B
Est 7790.0B
+54.7%
Nov 15
β€”
Aug 16, 21
βœ—
-0.25
Est -0.08
-212.5%
6427.0B
Est 6900.0B
-6.9%
Aug 16
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener